In Brief | Published:


Recombinant IL-1Ra as first-line therapy in sJIA

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


    Original article

    1. ter Haar, N. M. et al. Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study. Arthritis Rheumatol. (2019)

    Download references

    Author information

    Correspondence to Joanna Collison.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark